New research demonstrates the ultra-sensitive SNV detection capabilities of ppmSeq technology, with error rates reaching as low as 8 x 10-8 for minimal residual disease applications.
New whole exome and transcriptome sequencing assay demonstrates high concordance with existing companion diagnostics while requiring minimal tissue input for biomarker detection.
NGS-based MRD testing offers unprecedented sensitivity and breadth in detecting low-frequency leukemic clones.
Researchers have developed a revolutionary method using DNA sequencing to rapidly and precisely measure metabolites critical for health.
Read More
Baylor Genetics has partnered with Epic’s Aura diagnostics suite, enabling ordering genetic tests and access results directly within the EHR.
Read More
Datar Cancer Genetics introduced a blood test that combines tumor-agnostic NGS and tumor-informed dd-PCR to detect MRD.
Read More
Researchers demonstrate the potential of long-read sequencing to diagnose rare genetic diseases faster and more accurately.
Read More
OGT’s SureSeq Myeloid MRD Panel offers a NGS solution for ultra-sensitive detection of MRD biomarkers in acute myeloid leukemia.
Read More
While serving the region, Doylestown Health has a small clinical laboratory. To better serve its community, it added NGS in 2023.Â
Read More
Two studies demonstrate the potential of a genomic screening platform to improve early detection of genetic diseases in newborns.
Read More
Delve Bio’s Delve Detect is a metagenomic sequencing test capable of quickly identifying over 68,000 pathogens from CSF.
Read More
A mNGS test offers a rapid, comprehensive solution to diagnose a broad range of pathogens in neurological and respiratory infections.
Read More
A study reveals that while diagnostic accuracy in genetic testing is consistent across racial groups, access disparities persist.
Read More
Biotia’s BIOTIA-ID Urine NGS Assay uses artificial intelligence (AI) and genomics to deliver rapid, highly accurate UTI diagnoses.
Read More
Illumina’s new MiSeq i100 Series sequencing systems provide faster, simpler, and more cost-efficient next-generation sequencing solutions.
Read More
Reducing the incidence of healthcare-associated infections, and the antimicrobial resistance they can trigger, is critical for patient care.
Read More
The next-generation sequencing assay delivers rapid and comprehensive genetic profiling for AML patients, guiding precise treatment decisions.
Read More
A new study emphasizes the potential of advanced sequencing techniques in improving outcomes for CRC patients with rare genetic variants.
Read More